National News Germany's BioNTech to buy CureVac to boost cancer research ANDRE PAIN Jun 12, 2025 BioNTech hopes its purchase of CureVac will help boost its research into cancer treatments
National News Germany's BioNTech to buy CureVac to boost cancer research AFP AFP Jun 12, 2025 Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms…
Lifestyle Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA Jun 3, 2025 TUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization …
